Skip to main content
Top
Published in:

01-12-2023 | Bariatric Surgery | Research

Prevalence of elevated alkaline phosphatase levels among post-bariatric surgery patients

Authors: Claudius Ciecko, Hayrettin Okut, Brent Lancaster, Tiffany Schwasinger-Schmidt

Published in: Langenbeck's Archives of Surgery | Issue 1/2023

Login to get access

Abstract

Introduction

Little is known about the prevalence of elevated alkaline phosphatase in post-bariatric surgery patients due to under-utilization of this test after surgery. Elevated alkaline phosphatase levels are caused by hepatobiliary disease or bone resorption, which can lead to gallstones and osteoporosis. Early, post-operative measurement of alkaline phosphatase can prevent complications, thus reducing morbidity and overall healthcare costs. The purpose of this study was to determine the prevalence of elevated alkaline phosphatase levels among post-operative bariatric surgery patients.

Methods

This was a retrospective study of patients 18 years or older, who underwent laparoscopic sleeve gastrectomy (LSG) at a Midwestern Weight Management Clinic between January 1, 2002 and December 31, 2020. Alkaline phosphatase levels, weight, body mass index (BMI), gamma-glutamyl transferase (GGT), parathyroid hormone (PTH), calcitriol, and calcitonin, vitamin D and multivitamin supplementation were measured at baseline, 3, 6, and 12 months post-surgery.

Results

Two hundred thirty patients with mean age of 47 years and BMI of 44.6 were included with 80.9% (n = 186) female. Alkaline phosphatase was elevated relative to baseline for 36.1% of patients (n = 52) at 3 months post-surgery, 42.4% of patients (n = 56) at 6 months, and 43.3% of patients (n = 45) at 12 months (p < 0.001). There were six cases of documented cholelithiasis post-surgery.

Conclusion

A significant proportion of participants experienced elevations in alkaline phosphatase following surgery, indicating that the prevalence of gallbladder pathology and bone resorption may be higher than previously thought. This merits additional investigation into these complications post-operatively to determine prevalence and avoid excess morbidity.
Literature
4.
go back to reference Ma IT, Madura JA 2nd (2015) Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol (NY) 11(8):526–35 Ma IT, Madura JA 2nd (2015) Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol (NY) 11(8):526–35
14.
go back to reference Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23(7):1640–4. https://doi.org/10.1007/s00464-008-0204-6. (Erratum in: Surg Endosc. 2009 Jul;23(7):1645. Martinez-Duartez, Pedro [added])CrossRefPubMed Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23(7):1640–4. https://​doi.​org/​10.​1007/​s00464-008-0204-6. (Erratum in: Surg Endosc. 2009 Jul;23(7):1645. Martinez-Duartez, Pedro [added])CrossRefPubMed
21.
go back to reference Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, Wróblewski T, Remiszewski P, Grodzicki M, Krawczyk M (2017) Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg 266(5):738–745. https://doi.org/10.1097/SLA.0000000000002397CrossRefPubMed Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, Wróblewski T, Remiszewski P, Grodzicki M, Krawczyk M (2017) Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg 266(5):738–745. https://​doi.​org/​10.​1097/​SLA.​0000000000002397​CrossRefPubMed
28.
go back to reference Borges-Canha M, Neves JS, Mendonça F, Silva MM, Costa C, Cabral PM, Guerreiro V, Lourenço R, Meira P, Salazar D, Ferreira MJ, Pedro J, Leite A, Viana S, Sande A, Belo S, Lau E, Freitas P, Carvalho D, CRIO group (2020) The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis. Obes Surg 30(8):2935–2941. https://doi.org/10.1007/s11695-020-04622-0CrossRefPubMed Borges-Canha M, Neves JS, Mendonça F, Silva MM, Costa C, Cabral PM, Guerreiro V, Lourenço R, Meira P, Salazar D, Ferreira MJ, Pedro J, Leite A, Viana S, Sande A, Belo S, Lau E, Freitas P, Carvalho D, CRIO group (2020) The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis. Obes Surg 30(8):2935–2941. https://​doi.​org/​10.​1007/​s11695-020-04622-0CrossRefPubMed
29.
go back to reference Manatsathit W, Leelasinjaroen P, Al-Hamid H, Szpunar S, Hawasli A (2016) The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study. Int J Surg 30:13–8. https://doi.org/10.1016/j.ijsu.2016.03.060. (Erratum in: Int J Surg. 2016 Nov;35:218. Leelasincharoen, Pornchai [corrected to Leelasinjaroen, Pornchai])CrossRefPubMed Manatsathit W, Leelasinjaroen P, Al-Hamid H, Szpunar S, Hawasli A (2016) The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study. Int J Surg 30:13–8. https://​doi.​org/​10.​1016/​j.​ijsu.​2016.​03.​060. (Erratum in: Int J Surg. 2016 Nov;35:218. Leelasincharoen, Pornchai [corrected to Leelasinjaroen, Pornchai])CrossRefPubMed
32.
go back to reference Achufusi TGO, Safadi AO, Mahabadi N. Ursodeoxycholic Acid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022 Achufusi TGO, Safadi AO, Mahabadi N. Ursodeoxycholic Acid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022
36.
go back to reference Boerlage TCC, Haal S, Maurits de Brauw L, Acherman YIZ, Bruin S, van de Laar AWJM, Moes DE, van Wagensveld BA, de Vries CEE, van Veen R, Schouten R, Dijkgraaf MG, Fockens P, Gerdes VEA, Voermans RP (2017) Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterol 17(1):164. https://doi.org/10.1186/s12876-017-0674-xCrossRefPubMedPubMedCentral Boerlage TCC, Haal S, Maurits de Brauw L, Acherman YIZ, Bruin S, van de Laar AWJM, Moes DE, van Wagensveld BA, de Vries CEE, van Veen R, Schouten R, Dijkgraaf MG, Fockens P, Gerdes VEA, Voermans RP (2017) Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterol 17(1):164. https://​doi.​org/​10.​1186/​s12876-017-0674-xCrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of elevated alkaline phosphatase levels among post-bariatric surgery patients
Authors
Claudius Ciecko
Hayrettin Okut
Brent Lancaster
Tiffany Schwasinger-Schmidt
Publication date
01-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 1/2023
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-023-03021-0
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now